Concepts (216)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| CD8-Positive T-Lymphocytes | 12 | 2025 | 452 | 3.750 |
Why?
|
| Lymphocytic Choriomeningitis | 6 | 2022 | 12 | 1.880 |
Why?
|
| Receptors, Glucocorticoid | 5 | 2018 | 128 | 1.600 |
Why?
|
| Programmed Cell Death 1 Receptor | 7 | 2025 | 137 | 1.580 |
Why?
|
| RNA, Long Noncoding | 4 | 2022 | 250 | 1.360 |
Why?
|
| Response Elements | 5 | 2018 | 107 | 1.330 |
Why?
|
| DNA | 5 | 2017 | 1682 | 1.200 |
Why?
|
| Lymphocytic choriomeningitis virus | 5 | 2022 | 15 | 1.070 |
Why?
|
| T-Lymphocyte Subsets | 3 | 2022 | 214 | 0.910 |
Why?
|
| Brain Neoplasms | 2 | 2023 | 1409 | 0.790 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 4 | 2025 | 145 | 0.720 |
Why?
|
| Tumor Microenvironment | 6 | 2025 | 698 | 0.630 |
Why?
|
| Transcriptome | 4 | 2022 | 1138 | 0.620 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2023 | 377 | 0.620 |
Why?
|
| T-Lymphocytes | 3 | 2023 | 1812 | 0.610 |
Why?
|
| Receptors, Mineralocorticoid | 2 | 2015 | 18 | 0.580 |
Why?
|
| Conserved Sequence | 2 | 2019 | 300 | 0.570 |
Why?
|
| Antigens, CD | 1 | 2019 | 451 | 0.560 |
Why?
|
| Cell Differentiation | 4 | 2023 | 2045 | 0.500 |
Why?
|
| Neoplasms | 5 | 2022 | 3038 | 0.500 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2016 | 673 | 0.480 |
Why?
|
| NF-kappa B | 1 | 2018 | 482 | 0.480 |
Why?
|
| Transcription, Genetic | 4 | 2019 | 1761 | 0.480 |
Why?
|
| RNA, Small Nucleolar | 1 | 2014 | 16 | 0.450 |
Why?
|
| Head and Neck Neoplasms | 3 | 2025 | 702 | 0.430 |
Why?
|
| Apoptosis | 2 | 2025 | 1946 | 0.420 |
Why?
|
| Receptors, Steroid | 1 | 2014 | 276 | 0.410 |
Why?
|
| Mice, Inbred C57BL | 8 | 2025 | 4879 | 0.390 |
Why?
|
| Lung Neoplasms | 1 | 2023 | 1787 | 0.390 |
Why?
|
| Antibodies, Viral | 4 | 2022 | 1211 | 0.360 |
Why?
|
| Immunologic Memory | 4 | 2022 | 200 | 0.360 |
Why?
|
| Evolution, Molecular | 1 | 2014 | 710 | 0.350 |
Why?
|
| RNA-Binding Proteins | 1 | 2014 | 622 | 0.330 |
Why?
|
| Glucocorticoids | 1 | 2012 | 403 | 0.320 |
Why?
|
| HeLa Cells | 3 | 2018 | 838 | 0.320 |
Why?
|
| Animals | 19 | 2025 | 36557 | 0.310 |
Why?
|
| Mice | 14 | 2025 | 19055 | 0.310 |
Why?
|
| Antibodies, Neutralizing | 3 | 2022 | 497 | 0.310 |
Why?
|
| DNA-Binding Proteins | 2 | 2014 | 2178 | 0.300 |
Why?
|
| Crystallography, X-Ray | 4 | 2018 | 394 | 0.290 |
Why?
|
| Protein Binding | 5 | 2017 | 1859 | 0.290 |
Why?
|
| NF-E2-Related Factor 2 | 2 | 2025 | 131 | 0.280 |
Why?
|
| Humans | 28 | 2025 | 134156 | 0.270 |
Why?
|
| Cell Proliferation | 1 | 2014 | 2563 | 0.270 |
Why?
|
| Binding Sites | 4 | 2021 | 1384 | 0.260 |
Why?
|
| Cytokines | 1 | 2012 | 1401 | 0.260 |
Why?
|
| Hepatitis A Virus Cellular Receptor 2 | 3 | 2023 | 15 | 0.260 |
Why?
|
| Gene Expression Regulation | 5 | 2022 | 2669 | 0.250 |
Why?
|
| Amino Acid Substitution | 2 | 2018 | 416 | 0.240 |
Why?
|
| Transcription Factors | 1 | 2015 | 2738 | 0.240 |
Why?
|
| Radiation Tolerance | 1 | 2025 | 67 | 0.240 |
Why?
|
| Protein Structure, Tertiary | 3 | 2017 | 787 | 0.230 |
Why?
|
| Models, Molecular | 3 | 2018 | 1148 | 0.230 |
Why?
|
| Cigarette Smoking | 1 | 2025 | 80 | 0.220 |
Why?
|
| Tobacco Smoke Pollution | 1 | 2025 | 94 | 0.220 |
Why?
|
| Amino Acid Sequence | 4 | 2016 | 2795 | 0.210 |
Why?
|
| Hepatocyte Nuclear Factor 1-alpha | 2 | 2019 | 18 | 0.200 |
Why?
|
| Base Sequence | 3 | 2017 | 3180 | 0.200 |
Why?
|
| Clone Cells | 1 | 2022 | 180 | 0.190 |
Why?
|
| Interleukin-2 | 1 | 2022 | 252 | 0.190 |
Why?
|
| Molecular Sequence Data | 3 | 2016 | 3980 | 0.180 |
Why?
|
| Allergy and Immunology | 1 | 2021 | 29 | 0.180 |
Why?
|
| Immunotherapy | 2 | 2023 | 752 | 0.170 |
Why?
|
| Virus Diseases | 1 | 2023 | 290 | 0.160 |
Why?
|
| CX3C Chemokine Receptor 1 | 1 | 2019 | 13 | 0.160 |
Why?
|
| Lymphoid Tissue | 1 | 2020 | 50 | 0.160 |
Why?
|
| Granzymes | 1 | 2019 | 48 | 0.160 |
Why?
|
| Papillomaviridae | 1 | 2020 | 191 | 0.160 |
Why?
|
| Cell Line, Tumor | 4 | 2025 | 3798 | 0.150 |
Why?
|
| Synteny | 1 | 2019 | 80 | 0.150 |
Why?
|
| Mutation | 5 | 2022 | 6338 | 0.150 |
Why?
|
| RNA, Untranslated | 1 | 2019 | 120 | 0.150 |
Why?
|
| Genes, Retinoblastoma | 1 | 2018 | 21 | 0.150 |
Why?
|
| Datasets as Topic | 1 | 2019 | 105 | 0.150 |
Why?
|
| HEK293 Cells | 2 | 2018 | 825 | 0.150 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2022 | 503 | 0.150 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2018 | 49 | 0.140 |
Why?
|
| Nucleic Acids | 1 | 2018 | 27 | 0.140 |
Why?
|
| B-Lymphocytes | 1 | 2020 | 551 | 0.140 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2018 | 328 | 0.140 |
Why?
|
| Retinoblastoma | 1 | 2018 | 117 | 0.130 |
Why?
|
| Transcription Factor AP-1 | 1 | 2017 | 112 | 0.130 |
Why?
|
| Retinal Neoplasms | 1 | 2018 | 103 | 0.130 |
Why?
|
| Interferon-gamma | 1 | 2019 | 538 | 0.130 |
Why?
|
| Protein Structure, Secondary | 2 | 2014 | 256 | 0.130 |
Why?
|
| Lymphocyte Activation | 1 | 2019 | 724 | 0.130 |
Why?
|
| Saccharomyces | 1 | 2016 | 13 | 0.130 |
Why?
|
| Drug Delivery Systems | 1 | 2018 | 232 | 0.130 |
Why?
|
| Mucous Membrane | 1 | 2016 | 92 | 0.120 |
Why?
|
| Signal Transduction | 2 | 2025 | 4934 | 0.120 |
Why?
|
| Allosteric Regulation | 1 | 2015 | 64 | 0.120 |
Why?
|
| Sequence Analysis, RNA | 1 | 2019 | 426 | 0.120 |
Why?
|
| Disease Models, Animal | 3 | 2025 | 4808 | 0.120 |
Why?
|
| Antibody Formation | 1 | 2016 | 281 | 0.120 |
Why?
|
| Immune System | 1 | 2016 | 98 | 0.120 |
Why?
|
| Biomedical Research | 1 | 2021 | 556 | 0.120 |
Why?
|
| Substrate Specificity | 1 | 2015 | 313 | 0.120 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2018 | 703 | 0.120 |
Why?
|
| Dengue Virus | 1 | 2016 | 134 | 0.120 |
Why?
|
| Dengue | 1 | 2016 | 122 | 0.120 |
Why?
|
| Pseudohypoaldosteronism | 1 | 2014 | 1 | 0.110 |
Why?
|
| Structural Homology, Protein | 1 | 2014 | 27 | 0.110 |
Why?
|
| Nanoparticles | 1 | 2018 | 290 | 0.110 |
Why?
|
| Physicians | 1 | 2021 | 639 | 0.110 |
Why?
|
| Binding, Competitive | 1 | 2014 | 194 | 0.110 |
Why?
|
| Stem Cells | 1 | 2019 | 754 | 0.110 |
Why?
|
| Gene Expression Profiling | 2 | 2019 | 1923 | 0.110 |
Why?
|
| Zika Virus | 1 | 2016 | 151 | 0.110 |
Why?
|
| Telomere Homeostasis | 1 | 2014 | 47 | 0.110 |
Why?
|
| Lipids | 1 | 2018 | 566 | 0.110 |
Why?
|
| Songbirds | 1 | 2014 | 8 | 0.110 |
Why?
|
| Gene Expression | 2 | 2018 | 1621 | 0.110 |
Why?
|
| Gene Silencing | 1 | 2014 | 247 | 0.110 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2014 | 307 | 0.100 |
Why?
|
| Probiotics | 1 | 2016 | 229 | 0.100 |
Why?
|
| Sequence Alignment | 1 | 2014 | 633 | 0.100 |
Why?
|
| Protein Isoforms | 1 | 2014 | 433 | 0.100 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2012 | 171 | 0.100 |
Why?
|
| Phosphatidylcholines | 1 | 2012 | 39 | 0.100 |
Why?
|
| Promoter Regions, Genetic | 2 | 2014 | 1433 | 0.090 |
Why?
|
| Protein Multimerization | 1 | 2012 | 152 | 0.090 |
Why?
|
| Databases, Genetic | 1 | 2014 | 507 | 0.090 |
Why?
|
| Cell Line | 2 | 2018 | 2864 | 0.090 |
Why?
|
| Models, Genetic | 1 | 2014 | 789 | 0.090 |
Why?
|
| Protein Biosynthesis | 1 | 2014 | 678 | 0.090 |
Why?
|
| Brain | 1 | 2023 | 3224 | 0.090 |
Why?
|
| Behavior, Animal | 1 | 2014 | 522 | 0.090 |
Why?
|
| Recombinant Proteins | 1 | 2014 | 1440 | 0.090 |
Why?
|
| Microbiota | 1 | 2016 | 443 | 0.090 |
Why?
|
| Polymorphism, Genetic | 1 | 2014 | 897 | 0.080 |
Why?
|
| Female | 9 | 2025 | 71928 | 0.080 |
Why?
|
| Estrogen Receptor alpha | 1 | 2014 | 475 | 0.080 |
Why?
|
| Biomarkers | 1 | 2019 | 3434 | 0.080 |
Why?
|
| Inflammation | 1 | 2017 | 1595 | 0.080 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2012 | 396 | 0.080 |
Why?
|
| Escherichia coli | 1 | 2014 | 1027 | 0.080 |
Why?
|
| Neutralization Tests | 2 | 2021 | 238 | 0.070 |
Why?
|
| Hypoglycemic Agents | 1 | 2012 | 490 | 0.070 |
Why?
|
| MicroRNAs | 1 | 2014 | 951 | 0.070 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2025 | 2137 | 0.070 |
Why?
|
| Chromatin | 2 | 2022 | 617 | 0.070 |
Why?
|
| Kelch-Like ECH-Associated Protein 1 | 1 | 2025 | 37 | 0.060 |
Why?
|
| Prostatic Neoplasms | 1 | 2014 | 1626 | 0.060 |
Why?
|
| Smoke | 1 | 2025 | 68 | 0.060 |
Why?
|
| Male | 4 | 2019 | 66127 | 0.050 |
Why?
|
| Cellular Reprogramming | 1 | 2025 | 137 | 0.050 |
Why?
|
| T Cell Transcription Factor 1 | 1 | 2022 | 7 | 0.050 |
Why?
|
| Interleukin Receptor Common gamma Subunit | 1 | 2022 | 12 | 0.050 |
Why?
|
| Interleukin-2 Receptor beta Subunit | 1 | 2022 | 6 | 0.050 |
Why?
|
| Nucleocapsid | 1 | 2022 | 8 | 0.050 |
Why?
|
| CD28 Antigens | 1 | 2022 | 81 | 0.050 |
Why?
|
| Antigens, Surface | 1 | 2022 | 120 | 0.050 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 1 | 2022 | 54 | 0.050 |
Why?
|
| Antibodies | 1 | 2023 | 382 | 0.050 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2025 | 1012 | 0.050 |
Why?
|
| Breast Neoplasms | 1 | 2014 | 2771 | 0.050 |
Why?
|
| Mammals | 1 | 2022 | 282 | 0.040 |
Why?
|
| Somatic Hypermutation, Immunoglobulin | 1 | 2020 | 20 | 0.040 |
Why?
|
| Germinal Center | 1 | 2020 | 38 | 0.040 |
Why?
|
| Epitopes | 1 | 2022 | 446 | 0.040 |
Why?
|
| Epigenomics | 1 | 2022 | 196 | 0.040 |
Why?
|
| Receptors, Virus | 1 | 2021 | 111 | 0.040 |
Why?
|
| Plasma Cells | 1 | 2020 | 57 | 0.040 |
Why?
|
| Receptors, CXCR5 | 1 | 2020 | 6 | 0.040 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2023 | 456 | 0.040 |
Why?
|
| Immunity, Humoral | 1 | 2020 | 76 | 0.040 |
Why?
|
| Cell Separation | 1 | 2020 | 234 | 0.040 |
Why?
|
| Immunogenicity, Vaccine | 1 | 2021 | 114 | 0.040 |
Why?
|
| Lymphocytes | 1 | 2022 | 442 | 0.040 |
Why?
|
| Antigen Presentation | 1 | 2019 | 117 | 0.040 |
Why?
|
| Viral Vaccines | 1 | 2022 | 345 | 0.040 |
Why?
|
| Oxidative Stress | 1 | 2025 | 877 | 0.040 |
Why?
|
| Stem Cell Niche | 1 | 2019 | 58 | 0.040 |
Why?
|
| Tumor Escape | 1 | 2019 | 65 | 0.040 |
Why?
|
| Transforming Growth Factor beta | 1 | 2022 | 488 | 0.040 |
Why?
|
| Mice, Transgenic | 1 | 2025 | 2539 | 0.040 |
Why?
|
| Leadership | 1 | 2021 | 243 | 0.040 |
Why?
|
| Phenotype | 2 | 2022 | 4598 | 0.040 |
Why?
|
| Drug Therapy, Combination | 1 | 2022 | 1200 | 0.040 |
Why?
|
| Anaplasia | 1 | 2018 | 7 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 1 | 2019 | 399 | 0.040 |
Why?
|
| Nanotechnology | 1 | 2018 | 52 | 0.040 |
Why?
|
| Immunoglobulin G | 1 | 2020 | 825 | 0.030 |
Why?
|
| Neoplasm Grading | 1 | 2018 | 307 | 0.030 |
Why?
|
| Single-Cell Analysis | 1 | 2020 | 358 | 0.030 |
Why?
|
| Vaccination | 1 | 2022 | 1017 | 0.030 |
Why?
|
| Nucleic Acid Conformation | 1 | 2017 | 198 | 0.030 |
Why?
|
| Genetic Markers | 1 | 2018 | 635 | 0.030 |
Why?
|
| Vero Cells | 1 | 2016 | 113 | 0.030 |
Why?
|
| Papillomavirus Infections | 1 | 2020 | 396 | 0.030 |
Why?
|
| Immunoenzyme Techniques | 1 | 2016 | 258 | 0.030 |
Why?
|
| Cross Reactions | 1 | 2016 | 195 | 0.030 |
Why?
|
| Viral Envelope Proteins | 1 | 2016 | 156 | 0.030 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2020 | 872 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 1 | 2020 | 1072 | 0.030 |
Why?
|
| Epigenesis, Genetic | 1 | 2019 | 773 | 0.030 |
Why?
|
| Endothelial Cells | 1 | 2018 | 544 | 0.030 |
Why?
|
| Animal Communication | 1 | 2014 | 5 | 0.030 |
Why?
|
| Monocytes | 1 | 2016 | 360 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2016 | 548 | 0.030 |
Why?
|
| Flow Cytometry | 1 | 2016 | 837 | 0.030 |
Why?
|
| Macrophages | 1 | 2018 | 711 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2016 | 1332 | 0.030 |
Why?
|
| Disease Progression | 1 | 2019 | 2266 | 0.030 |
Why?
|
| Biological Evolution | 1 | 2014 | 256 | 0.020 |
Why?
|
| Nuclear Receptor Co-Repressor 2 | 1 | 2012 | 38 | 0.020 |
Why?
|
| Haplotypes | 1 | 2014 | 560 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2018 | 3188 | 0.020 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2012 | 117 | 0.020 |
Why?
|
| Nuclear Receptor Coactivator 2 | 1 | 2012 | 211 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2016 | 964 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2016 | 2915 | 0.020 |
Why?
|
| Diabetes Mellitus | 1 | 2012 | 937 | 0.010 |
Why?
|
| Risk Factors | 1 | 2018 | 11182 | 0.010 |
Why?
|
| Infant | 1 | 2018 | 13240 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2018 | 14884 | 0.010 |
Why?
|